Commercial Credit Report for Pcas SA

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Pcas SA is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pcas SA

21 Chemin de la Sauvegarde, Ecully Cedex

Phone: +33 169097785p:+33 169097785

ECULLY, 69134 France

Ticker: PCAPCA

This company is no longer actively traded on any major stock exchange.

This is a Subsidiary, click here for the Parent Company

Business Summary

Pcas SA, formerly Produits Chimiques Auxiliaires Et De Synthese SA, is a France-based company engaged in the development and manufacture of complex molecules for life sciences and specialty chemicals markets. It operates through nine production sites and two main business units, Pharma Synthesis and Fine & Specialty Chemicals. Pharma Synthesis unit specializes in active pharmaceutical ingredients (API), intermediates and building blocks, and early phase services, among others. Fine & Specialty Chemicals unit focuses on custom manufacturing and proprietary products, such as fragrance, flavor ingredients, imaging and microelectronics chemicals. The Company operates several subsidiaries, including Saint-Jean Photochimie, Societe Bearnaise de Synthese, Expansia, PCAS BioMatrix Inc, based in Canada, and PCAS Finland Oy, based in Finland, among others.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	Yes	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
6/30/2023	12/31/2022	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations
2865	Cyclic organic crudes and intermediates, and organic dyes and pigments
3861	Photographic equipment and supplies
2899	Chemicals and chemical preparations, not elsewhere classified
8711	Engineering services
8731	Commercial physical and biological research

Officers and Directors

Title	Name	Age	Title Date	Start Date
Chairman of the Board, Chief Executive Officer	PierreLuzeau	56	3/23/2020	6/20/2017
Deputy Chief Executive Officer, Member of the Executive Committee	PhilippeClavel		1/1/2020	1/1/2020
Deputy Chief Executive Officer, Member of the Executive Committee	SebastienTaillemite		1/1/2018	1/1/2018
4 additional Officers and Directors records available in full report.

Business Names

Business Name
Expansia
PCA
PCAS
4 additional Business Names available in full report.

General Information

Number of Employees:	1,178	(As of 6/30/2023)
Outstanding Shares:	13,741,673	(As of 6/30/2023)
Shareholders:	1,164
Stock Exchange:	EPA
Fax Number:	+33 164482319

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN